Amid GMO Strife, Food Industry Vies For Public Trust In CRISPR Technology – NPR
NPR |
Amid GMO Strife, Food Industry Vies For Public Trust In CRISPR Technology
NPR Dozens of crops and livestock developed with CRISPR technology are years from the market, though the U.S. Department of Agriculture already said it won’t regulate CRISPR-developed products like other genetically engineered food, since no foreign … |
Labiotech.eu (blog) |
The UK’s NICE Recommends GSK’s €594000 Gene Therapy
Labiotech.eu (blog) Amidst uncertainty about the commercial future of expensive gene therapies, the UK’s NICE has declared GSK’s Strimvelis offers “value for money.” Approved by the EMA last year, Strimvelis is one of the most expensive drugs on the market. Although GSK … |
Dove Medical Press |
Hematopoietic stem cell transplantation in a severe refractory Crohn’s disease patient with intestinal stoma: a case …
Dove Medical Press Background: Hematopoietic stem cell transplantation (HSCT) can be used in the treatment of patients with refractory Crohn’s disease (CD) when no alternative treatment is available. However, HSCT increases the risk of infections, in particular during … |
NBC 6 South Florida |
Local 4-Year-Old Boy’s Cancer in Remission After Experimental Stem Cell Treatment at UM
NBC 6 South Florida The Flash is the favorite superhero of 4-year-old Jovon Moss, who is his mother’s real-life hero as he is fighting a rare form of lymphoma through an experimental stem cell treatment. Jovon is being treated in the Alex’s Place pediatric center that’s … Stem cell therapy combats a one-in-a-million immune disorder for 4-year-old boyMiami Herald |